Abstract:Tumor metastasis is the cause of death for 90% of cancer patients, and no currently-available therapies target this multi-step process in which cancer cells spread from the local tissue of a primary tumor to distant organs where they establish secondary tumors. Although epithelial-to-mesenchymal transition, tumor-secreted exosomes, epigenetic regulators as well as other genes have been implicated in metastasis, little is known about how cells adapt to and colonize new tissue environments. Here, we show that the epigenetics-mediated reprogramming of tissue-specific gene transcription in cancer cells promotes metastasis. Using colorectal cancer (CRC) as a model, we found in both clinical and cell line studies that metastatic CRC cells lose their colon-specific gene transcription program and gain a liver-specific gene transcription program as they metastasize in the liver. Further, we found this transcription reprogramming is driven by a reshaped epigenetic landscape of both typical and super-enhancers. Chemical inhibition of enhancer activity disrupts the ability of cells to execute altered transcription programs and consequently inhibits metastasis. Binding motif analysis of the enhancers in liver metastatic CRC cells identified the liver-specific transcription factor FOXA2 as a key regulator, and knocking down of FOXA2 expression prevents the colonization of metastatic CRC cells in the liver of a mice xenograft model. These results, together with additional observations of similar reprogramming in several cohorts of clinical CRC tumor samples and in multiple other forms of metastatic cancers, indicate that this reprogramming may be a common feature of metastasis in multiple cancers and suggest the targeted disruption of this epigenetic reprogramming as a strategy for the development of therapies to treat metastasis, the leading cause of cancer-related mortality.

Progress on Molecular Mechanisms of Tumor Metastasis Regulated by Transcription Factors

Research Progress in the Mechanism of Molecular Targeted Anti-tumor Drugs

Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications

Transcription Factors As New Targets for Cancer Therapy

The Role of MicroRNA in the Regulation of Tumor Epithelial–Mesenchymal Transition

Progress in mechanism of tumor metastatic colonization

Molecular Insights into Tumour Metastasis: Tracing the Dominant Events

The research progress of epithelial-mesenchymal transition in tumor invasion and metastasis

Research Advances in EMT Transcription Factors and Their Regulatory Mechanisms

Epithelial–mesenchymal transition in colorectal cancer metastasis: A system review

Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives

Research progress of epithelial-mesenchymal transformation-related transcription factors in peritoneal metastases

Epigenetic Reprogramming of Tissue-Specific Transcription Promotes Metastasis

Noncoding RNAs in Tumor Metastasis: Molecular and Clinical Perspectives.

Targeting Key Proteins Involved in Transcriptional Regulation for Cancer Therapy: Current Strategies and Future Prospective.

Tumor Metastasis: Mechanistic Insights and Therapeutic Interventions

Molecular mechanisms of microRNAs in regulating epithelial–mesenchymal transitions in human cancers

Updates on mechanistic insights and targeting of tumour metastasis

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis

Progress of Functional Mechanism of Lncrna in the Metastasis of Stomach Neoplasms

Multi-stage mechanisms of tumor metastasis and therapeutic strategies